
1. malar res treat. 2016;2016:9694372. doi: 10.1155/2016/9694372. epub 2016 apr 17.

increased prevalence mutant allele pfdhps 437g pfdhfr triple mutation in
plasmodium falciparum isolates rural area gabon, three years 
change malaria treatment policy.

ndong ngomo jm(1), mawili-mboumba dp(1), m'bondoukwe np(1), nikiéma ndong ella
r(1), bouyou akotet mk(1).

author information: 
(1)department parasitology-mycology tropical medicine, faculty of
medicine, université des sciences de la santé, bp 4009, libreville, gabon.

in gabon, sulfadoxine-pyrimethamine (sp) recommended intermittent
preventive treatment pregnancy (iptp-sp) uncomplicated malaria
treatment acts drug. p. falciparum strains resistant sp frequent
in areas drug highly used associated occurrence 
mutations plasmodium falciparum dihydrofolate reductase (pfdhfr) and
dihydropteroate synthetase (pfdhps) genes. aim study compare
the proportion mutations pfdhfr pfdhps genes isolates collected at
oyem northern gabon, 2005 time iptp-sp introduction three
years later. point mutations analyzed nested pcr-rflp method. among 91
isolates, 90% carried pfdhfr 108n pfdhfr 59r alleles. frequencies
of pfdhfr 51i (98%) pfdhps 437g (67.7%) mutant alleles higher 2008.
mutations codons 164, 540, 581 detected. proportion the
triple pfdhfr mutation quadruple mutation including a437g high: 91.9% 
2008 64.8% 2008, respectively. present study highlights elevated
frequency pfdhfr pfdhps mutant alleles, although quintuple mutations 
not found north gabon. data suggest need continuous monitoring 
of sp resistance gabon.

doi: 10.1155/2016/9694372 
pmcid: pmc4852121
pmid: 27190671 

